Skip NavigationSkip to Content

Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy

  1. Author:
    Rosa, Lorena [ORCID]
    Cook, Paz
    Pfeiffer, Ruth M [ORCID]
    Kemp,Troy
    Hildesheim, Allan [ORCID]
    Pehlivanoglu, Burcin
    Adsay, Volkan
    Bellolio, Enrique
    Araya, Juan Carlos
    Pinto,Ligia
    Ferreccio, Catterina
    Aguayo, Gloria
    Viñuela, Eduardo
    Koshiol, Jill [ORCID]
  2. Author Address

    1Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. 2Advanced Center for Chronic Diseases, Universidad de Chile and Pontificia Universidad Católica de Chile, Santiago, Chile. 3Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 4Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. 5Vaccine, Immunity and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA. 6Department of Pathology, Dokuz Eylul University, Izmir, Turkey. 7Department of Pathology, Koç University School of Medicine and Koç University Research Center for Translational Medicine, Istanbul, Turkey. 8Departamento de Anatomía Patológica, Universidad de La Frontera, Temuco, Chile. 9Departamento de Patología, Hospital Dr. Hernán Henríquez Aravena, Temuco, Chile. 10Anatomía Patológica, Hospital Sótero del Río, Santiago, Chile. 11UDA Hospital Sótero del Río, Facultad de Medicina, Pontificia Universidad Católi
    1. Year: 2024
    2. Date: Oct 31
    3. Epub Date: 2024 10 31
  1. Journal: International Journal of Cancer
  2. Type of Article: Article
  1. Abstract:

    Inflammation has been associated with the development of gallbladder cancer (GBC). However, little is known about the associations of both, inflammation and the use of non-steroidal anti-inflammatory drugs (NSAIDs), with preneoplastic lesions. We analyzed the association of NSAIDs and gallbladder dysplasia in 82 patients with dysplasia and 1843 patients with gallstones among symptomatic patients from a high-risk population. We also analyzed associations for 33 circulating immune-related proteins in a subsample of all 68 dysplasia cases diagnosed at the time of sample selection and 136 gallstone controls. We calculated age- and sex-adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs). Biliary colic was reported among most cases (97.6%) and controls (83.9%). NSAID use was inversely associated with gallbladder dysplasia (OR: 0.48, 95%CI: 0.26-0.83). Comparing the highest versus lowest category of each immune-related protein, eight proteins were inversely associated with dysplasia with sex- and age-adjusted ORs ranging from 0.30 (95%CI: 0.12-0.77) for IL-33 to 0.76 (95%CI: 0.59-0.99) for MIP-1B. Of those, GRO remained associated with dysplasia (OR: 0.64, 95%CI: 0.45-0.91) and BCA-1 was borderline associated (OR: 0.74, 95%CI: 0.54-1.01) after adjusting the logistic regression model for sex, age, and NSAIDs. In conclusion, NSAID users were less likely to have gallbladder dysplasia, suggesting that NSAIDs might be beneficial for symptomatic gallstones patients. The inverse association between immune-related markers and dysplasia requires additional research, ideally in prospective studies with asymptomatic participants, to understand the role of the inflammatory response in the natural history of GBC and to address the biological effect of NSAIDs. © 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

    See More

External Sources

  1. DOI: 10.1002/ijc.35238
  2. PMID: 39482824

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel